OncoCompass® is a CE-marked liquid biopsy kit for comprehensive cancer mutation profiling using circulating tumor DNA analysis. Designed for non-invasive oncology assessment, it enables detection and characterization of cancer-associated mutations from blood samples to support treatment planning and...
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Xi'an Tianlong Science And Technology Co., Ltd
China · 1 relevant product
GeneCker Co., Ltd.
South Korea · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
APPOLON BIOTECK SAS
France · 1 relevant product
Biopsense Oy
Finland · 4 relevant products
International Company for medical eq.
Egypt · 1 relevant product
Axbio (shenzhen) Co.,LTD
China · 1 relevant product
Bio-Techne Diagnostics
United States · 2 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 4 relevant products
Shanghai Devulon Material Co.,Ltd
China · 1 relevant product
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 95 closest product alternatives
Xi'an Tianlong Science And Technology Co., Ltd · China
Molecular diagnostic kit for detecting genetic mutations and biomarkers associated with cancer. Supports precision oncology testing for treatment selection and monitoring.
GeneCker Co., Ltd. · South Korea
A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
APPOLON BIOTECK SAS · France
In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
International Company for medical eq. · Egypt
Molecular diagnostic testing for cancer detection and monitoring.
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
Axbio (shenzhen) Co.,LTD · China
Molecular diagnostic kit for cancer genomics profiling and tumor mutation analysis. Enables detection of somatic mutations relevant to oncology and cancer treatment planning.
Bio-Techne Diagnostics · United States
Advanced molecular assays for liquid biopsy applications enabling non-invasive detection of circulating biomarkers. Integrated with automated analysis for scalable clinical implementation.
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
Shanghai Devulon Material Co.,Ltd · China
A companion diagnostic test kit designed for detecting KRAS mutations in cancer samples. This kit is used in conjunction with specific therapeutic treatments for patients with companion diagnostic indications. The kit includes quality control materials and has been validated for clinical use in tumor sample analysis.
83 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products